Safety and efficacy of GLP-1/FGF21 dual agonist HEC88473 in MASLD and T2DM: A randomized, double-blind, placebo-controlled study. Xiang L, Wang G, Zhuang Y, Luo L, et al. J Hepatol 2025;82:967-978.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xiang L, Wang G, Zhuang Y, Luo L, et al. Safety and efficacy of GLP-1/FGF21 dual agonist HEC88473 in MASLD and T2DM: A randomized, double-blind, placebo-controlled study. J Hepatol 2025;82:967-978.
PMID: 39709140